Correction to: PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity

被引：0
|
作者：
Siyuan Zha
Zhen Li
Qing Cao
Fei Wang
Fang Liu
机构：
[1] Shanghai Jiao Tong University,Department of Geriatrics, Xinhua Hospital, School of Medicine
来源：
Stem Cell Research & Therapy | / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The original article [1] contains an error regarding the erroneous inclusion of 3 μl as a parameter in the x-axis of Fig. 2c; the correct version of Fig. 2c can instead be seen below.
引用
收藏
相关论文
共 4 条
  • [1] PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity
    Zha, Siyuan
    Li, Zhen
    Cao, Qing
    Wang, Fei
    Liu, Fang
    STEM CELL RESEARCH & THERAPY, 2018, 9
  • [2] PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity
    Siyuan Zha
    Zhen Li
    Qing Cao
    Fei Wang
    Fang Liu
    Stem Cell Research & Therapy, 9
  • [3] PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity (vol 9, pg 224, 2018)
    Zha, Siyuan
    Li, Zhen
    Cao, Qing
    Wang, Fei
    Liu, Fang
    STEM CELL RESEARCH & THERAPY, 2018, 9
  • [4] PJ34, a PARP1 inhibitor, promotes endothelial repair in a rabbit model of high fat diet-induced atherosclerosis
    Zha, Siyuan
    Wang, Fei
    Li, Zhen
    Ma, Zhiyuan
    Yang, Ling
    Liu, Fang
    CELL CYCLE, 2019, 18 (17) : 2099 - 2109
1